X0306 4 2016-02-23 0 0001593034 Endo International plc ENDP 0001542052 Hall Susan C/O ENDO INTERNATIONAL PLC MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE, DUBLIN 4 L2 0 IRELAND 0 1 0 0 EVP, CSO, Global Head of R&D Stock Incentive Plan Performance Shares 2016-02-23 4 A 0 13331 A 27071 D Stock Incentive Plan Restricted Stock Units (RSU) 2016-02-23 4 A 0 6665 A 14180 D Ordinary Shares 2016-02-24 4 F 0 239 49.85 D 3160 D 2015 Stock Incentive Plan Stock Options (NQ) 50.22 2016-02-23 4 A 0 22481 A 2026-02-23 Ordinary Shares 22481 22481 D The performance shares vest upon Endo International plc achieving certain shareholder return performance metrics over a cumulative three-year period. Represents the target number of shares issuable upon Endo International plc's achievement of shareholder return performance metrics over a cumulative three-year period, as determined by Endo International plc's Board of Directors at the end of such three-year period. The ultimate number of shares issued may be between 0% and 300% of the target number of shares, depending on Endo International plc's shareholder return performance metrics results over the performance period. These securities were granted to Ms. Hall in consideration of her services as the Executive Vice President, Chief Scientific Officer, Global Head of R&D of Endo International plc. Represents the cumulative target number of shares issuable with respect to all 2010 Stock Incentive Plan and 2015 Stock Incentive Plan performance shares outstanding. The cumulative total is the combination of the target payouts for the current grant and all past grants made under the 2010 Stock Incentive Plan and 2015 Stock Incentive Plan and still outstanding, which are subject to a range of payouts depending on Endo International plc's achievement of certain performance metrics as described herein for the current grants and as previously disclosed for all other performance share grants. Upon each vesting date, each vested restricted stock unit automatically converts into one (1) ordinary share of Endo International plc. These restricted stock units (RSUs) generally vest 25% per year on each of February 23, 2017, February 23, 2018, February 23, 2019 and February 23, 2020. Upon vesting, we consider the underlying RSUs to be expired. Twenty-five percent (25%) of Ms. Hall's February 24, 2015 grant of restricted stock units (RSUs) vested on February 24, 2016. These shares represent stock withheld by Endo International plc to satisfy Ms. Hall's tax withholding obligations on shares acquired upon vesting of RSUs. $49.85 represents the vesting price, which is the average of the high and low share price on February 24, 2016. Represents the right to buy ordinary shares, par value $0.0001 per share, of Endo International plc. These stock options are generally exercisable 25% per year on each of February 23, 2017, February 23, 2018, February 23, 2019 and February 23, 2020. /s/ Matthew J. Maletta, by power of attorney 2016-02-25